Many studies have demonstrated the overexpression of heparanase and HPSE2, especially in invasive solid tumors in comparison with benign lesions.[37] However, there is little data demonstrating that these proteins are valid markers for malignant tumor diagnosis. The gene discussed is HPSE2; the disease is cancer.